Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for
Pimecrolimus Cream, 1%, a generic version of Elidel1 Cream, 1%, of Bausch Health US, LLC.
According to IQVIATM sales data for the 12 month period ending July 2019, the Elidel Cream, 1% market2 achieved annual sales of approximately $198.8 million.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
